{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T02:40:23Z","timestamp":1783132823547,"version":"3.54.6"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:00:00Z","timestamp":1648512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:00:00Z","timestamp":1648512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"national heart, lung, and blood institute","doi-asserted-by":"publisher","award":["K23 HL153774"],"award-info":[{"award-number":["K23 HL153774"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Data on the relations between kidney function abnormalities and stroke in type 2 diabetes are limited. We evaluated the associations of kidney function abnormalities and chronic kidney disease (CKD) stages with incident stroke in a large sample of adults with type 2 diabetes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Participants with type 2 diabetes from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study without history of stroke at baseline were included. Urine albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR) were assessed at baseline. CKD categories were defined according to the KDIGO (Kidney Disease: Improving Global Outcomes) guidelines. Cox proportional hazards regression models were used to compute hazard ratios (HR) and 95% confidence intervals (CI) for stroke in relation to measures of kidney function and CKD categories.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 9170 participants (mean age 62.8 [SD: 6.6] years, 38.2% women, 62.9% white) were included. Over a median follow-up of 4.9\u2009years (interquartile range: 4.0\u20135.7), 156 participants developed a stroke (incidence rate 3.6\/1000 person-years [95% CI 3.0\u20134.2]). After adjusting for relevant confounders, higher UACR and lower eGFR were each associated with increased risk of stroke. Compared to UACR &lt;\u200930\u2009mg\/g, moderate albuminuria and severe albuminuria were associated with increasing hazards for stroke (HR 1.61 [95% CI 1.12\u20132.32] and 2.29 [95% CI 1.39\u20133.80], respectively). Compared to eGFR of \u2265\u200960\u2009mL\/min\/1.73\u00a0m<jats:sup>2<\/jats:sup>, decreased eGFR (eGFR &lt;\u200960\u2009mL\/min\/1.73\u00a0m<jats:sup>2<\/jats:sup>) was associated with higher risk of stroke (HR 1.50, 95% CI 0.98\u20132.29). Compared to no CKD, worsening CKD stage was associated with an increasing risk of stroke (HRs of 1.76 [95% CI 1.10\u20132.83] for CKD G1, 1.77 [95% CI 1.13\u20132.75] for CKD G2, and 2.03 [95% CI 1.27\u20133.24] for CKD G3).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In a large sample of adults with type 2 diabetes, increasing albuminuria and worsening stages of early CKD were independently associated with higher risk of incident stroke.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov. Identifier: <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00000620\">NCT00000620<\/jats:ext-link>.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12916-022-02317-0","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T01:03:50Z","timestamp":1648515830000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Diabetic kidney disease and risk of incident stroke among adults with type 2 diabetes"],"prefix":"10.1186","volume":"20","author":[{"given":"Arnaud D.","family":"Kaze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard G.","family":"Jaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg C.","family":"Fonarow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin B.","family":"Echouffo-Tcheugui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,29]]},"reference":[{"issue":"9","key":"2317_CR1","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","volume":"141","author":"SS Virani","year":"2020","unstructured":"Virani SS, Alonso A, Benjamin EJ, et al. Heart Disease and Stroke Statistics-2020 update: a report from the American Heart Association. Circulation. 2020;141(9):e139\u2013596. https:\/\/doi.org\/10.1161\/CIR.0000000000000757.","journal-title":"Circulation"},{"issue":"10","key":"2317_CR2","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1001\/jama.2015.10029","volume":"314","author":"A Menke","year":"2015","unstructured":"Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988-2012. JAMA. 2015;314(10):1021\u20139. https:\/\/doi.org\/10.1001\/jama.2015.10029.","journal-title":"JAMA"},{"issue":"12","key":"2317_CR3","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.2337\/dc06-1537","volume":"30","author":"EL Air","year":"2007","unstructured":"Air EL, Kissela BM. Diabetes, the metabolic syndrome, and ischemic stroke: epidemiology and possible mechanisms. Diabetes Care. 2007;30(12):3131\u201340. https:\/\/doi.org\/10.2337\/dc06-1537.","journal-title":"Diabetes Care"},{"issue":"7","key":"2317_CR4","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.2337\/dc07-0264","volume":"30","author":"N Cheung","year":"2007","unstructured":"Cheung N, Wang JJ, Klein R, Couper DJ, Sharrett AR, Wong TY. Diabetic retinopathy and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study. Diabetes Care. 2007;30(7):1742\u20136. https:\/\/doi.org\/10.2337\/dc07-0264.","journal-title":"Diabetes Care"},{"issue":"2","key":"2317_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2337\/dc06-1747","volume":"30","author":"A Juutilainen","year":"2007","unstructured":"Juutilainen A, Lehto S, R\u00f6nnemaa T, Py\u00f6r\u00e4l\u00e4 K, Laakso M. Retinopathy predicts cardiovascular mortality in type 2 diabetic men and women. Diabetes Care. 2007;30(2):292\u20139. https:\/\/doi.org\/10.2337\/dc06-1747.","journal-title":"Diabetes Care"},{"issue":"1","key":"2317_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.atherosclerosis.2011.06.029","volume":"218","author":"RS Rosenson","year":"2011","unstructured":"Rosenson RS, Fioretto P, Dodson PM. Does microvascular disease predict macrovascular events in type 2 diabetes? Atherosclerosis. 2011;218(1):13\u20138. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2011.06.029.","journal-title":"Atherosclerosis"},{"key":"2317_CR7","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1016\/j.jacc.2019.03.002","volume":"73","author":"S Verma","year":"2019","unstructured":"Verma S, Wanner C, Zwiener I, et al. Influence of microvascular disease on cardiovascular events in type 2 diabetes. J. Am. Coll. Cardiol. 2019;73:2780\u20132.","journal-title":"J. Am. Coll. Cardiol."},{"issue":"12","key":"2317_CR8","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1161\/STROKEAHA.120.030350","volume":"51","author":"K-H Wong","year":"2020","unstructured":"Wong K-H, Hu K, Peterson C, et al. Diabetic retinopathy and risk of stroke: a secondary analysis of the ACCORD Eye study. Stroke. 2020;51(12):3733\u20136. https:\/\/doi.org\/10.1161\/STROKEAHA.120.030350.","journal-title":"Stroke"},{"issue":"11","key":"2317_CR9","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1161\/STROKEAHA.119.025442","volume":"50","author":"DM Kelly","year":"2019","unstructured":"Kelly DM, Rothwell PM. Does chronic kidney disease predict stroke risk independent of blood pressure?: a systematic review and meta-regression. Stroke. 2019;50(11):3085\u201392. https:\/\/doi.org\/10.1161\/STROKEAHA.119.025442.","journal-title":"Stroke"},{"issue":"11","key":"2317_CR10","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1161\/STROKEAHA.110.581215","volume":"41","author":"M Lee","year":"2010","unstructured":"Lee M, Saver JL, Chang K-H, Liao H-W, Chang S-C, Ovbiagele B. Impact of microalbuminuria on incident stroke: a meta-analysis. Stroke. 2010;41(11):2625\u201331. https:\/\/doi.org\/10.1161\/STROKEAHA.110.581215.","journal-title":"Stroke"},{"issue":"15","key":"2317_CR11","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1212\/WNL.0b013e3181f73638","volume":"75","author":"MI Aguilar","year":"2010","unstructured":"Aguilar MI, O\u2019Meara ES, Seliger S, et al. Albuminuria and the risk of incident stroke and stroke types in older adults. Neurology. 2010;75(15):1343\u201350. https:\/\/doi.org\/10.1212\/WNL.0b013e3181f73638.","journal-title":"Neurology"},{"key":"2317_CR12","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.kint.2020.02.010","volume":"97","author":"AS Levey","year":"2020","unstructured":"Levey AS, Eckardt K-U, Dorman NM, et al. Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference. Kidney Int. 2020;97:1117\u201329.","journal-title":"Kidney Int."},{"issue":"12A","key":"2317_CR13","doi-asserted-by":"publisher","first-page":"21i","DOI":"10.1016\/j.amjcard.2007.03.003","volume":"99","author":"JB Buse","year":"2007","unstructured":"Buse JB, Bigger JT, Byington RP, et al. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol. 2007;99(12A):21i\u201333i. https:\/\/doi.org\/10.1016\/j.amjcard.2007.03.003.","journal-title":"Am J Cardiol"},{"issue":"9739","key":"2317_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","volume":"376","author":"F Ismail-Beigi","year":"2010","unstructured":"Ismail-Beigi F, Craven T, Banerji MA, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet (London, England). 2010;376(9739):419\u201330. https:\/\/doi.org\/10.1016\/S0140-6736(10)60576-4.","journal-title":"Lancet (London, England)"},{"issue":"9","key":"2317_CR15","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006.","journal-title":"Ann Intern Med"},{"issue":"17","key":"2317_CR16","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","volume":"362","author":"WC Cushman","year":"2010","unstructured":"Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362(17):1575\u201385. https:\/\/doi.org\/10.1056\/NEJMoa1001286.","journal-title":"N Engl J Med"},{"issue":"5","key":"2317_CR17","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.2337\/dc11-1811","volume":"35","author":"JC Mychaleckyj","year":"2012","unstructured":"Mychaleckyj JC, Craven T, Nayak U, et al. Reversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participants. Diabetes Care. 2012;35(5):1008\u201314. https:\/\/doi.org\/10.2337\/dc11-1811.","journal-title":"Diabetes Care"},{"issue":"1","key":"2317_CR18","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.diabres.2009.01.009","volume":"84","author":"R Yamamoto","year":"2009","unstructured":"Yamamoto R, Kanazawa A, Shimizu T, et al. Association between atherosclerosis and newly classified chronic kidney disease stage for Japanese patients with type 2 diabetes. Diabetes Res Clin Pract. 2009;84(1):39\u201345. https:\/\/doi.org\/10.1016\/j.diabres.2009.01.009.","journal-title":"Diabetes Res Clin Pract"},{"key":"2317_CR19","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12933-015-0204-5","volume":"14","author":"L Cea Soriano","year":"2015","unstructured":"Cea Soriano L, Johansson S, Stefansson B, Rodr\u00edguez LAG. Cardiovascular events and all-cause mortality in a cohort of 57,946 patients with type 2 diabetes: associations with renal function and cardiovascular risk factors. Cardiovasc Diabetol. 2015;14:38. https:\/\/doi.org\/10.1186\/s12933-015-0204-5.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2317_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2337\/dc13-1931","volume":"37","author":"Y Luo","year":"2014","unstructured":"Luo Y, Wang X, Wang Y, et al. Association of glomerular filtration rate with outcomes of acute stroke in type 2 diabetic patients: results from the China National Stroke Registry. Diabetes Care. 2014;37(1):173\u20139. https:\/\/doi.org\/10.2337\/dc13-1931.","journal-title":"Diabetes Care"},{"issue":"13","key":"2317_CR21","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS, Chertow GM, Fan D, McCulloch CE, Hsu C. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296\u2013305. https:\/\/doi.org\/10.1056\/NEJMoa041031.","journal-title":"N Engl J Med"},{"issue":"7","key":"2317_CR22","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/j.1464-5491.2007.02145.x","volume":"24","author":"PCY Tong","year":"2007","unstructured":"Tong PCY, Kong AP, So WY, et al. Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with type 2 diabetes mellitus. Diabet Med. 2007;24(7):741\u20136. https:\/\/doi.org\/10.1111\/j.1464-5491.2007.02145.x.","journal-title":"Diabet Med"},{"issue":"12","key":"2317_CR23","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1111\/j.1464-5491.2008.02592.x","volume":"25","author":"H Yokoyama","year":"2008","unstructured":"Yokoyama H, Oishi M, Kawai K, Sone H. Reduced GFR and microalbuminuria are independently associated with prevalent cardiovascular disease in Type 2 diabetes: JDDM study 16. Diabet Med. 2008;25(12):1426\u201332. https:\/\/doi.org\/10.1111\/j.1464-5491.2008.02592.x.","journal-title":"Diabet Med"},{"key":"2317_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1475-2840-6-37","volume":"6","author":"X Yang","year":"2007","unstructured":"Yang X, Ma RC, So W-Y, et al. Impacts of chronic kidney disease and albuminuria on associations between coronary heart disease and its traditional risk factors in type 2 diabetic patients - the Hong Kong diabetes registry. Cardiovasc Diabetol. 2007;6:37. https:\/\/doi.org\/10.1186\/1475-2840-6-37.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"2317_CR25","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s00125-007-0616-1","volume":"50","author":"G Bruno","year":"2007","unstructured":"Bruno G, Merletti F, Bargero G, et al. Estimated glomerular filtration rate, albuminuria and mortality in type 2 diabetes: the Casale Monferrato study. Diabetologia. 2007;50(5):941\u20138. https:\/\/doi.org\/10.1007\/s00125-007-0616-1.","journal-title":"Diabetologia"},{"issue":"11","key":"2317_CR26","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1016\/j.jacc.2004.09.006","volume":"44","author":"H Knobler","year":"2004","unstructured":"Knobler H, Zornitzki T, Vered S, et al. Reduced glomerular filtration rate in asymptomatic diabetic patients: predictor of increased risk for cardiac events independent of albuminuria. J Am Coll Cardiol. 2004;44(11):2142\u20138. https:\/\/doi.org\/10.1016\/j.jacc.2004.09.006.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2317_CR27","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1161\/CIRCULATIONAHA.105.538132","volume":"112","author":"J Arnl\u00f6v","year":"2005","unstructured":"Arnl\u00f6v J, Evans JC, Meigs JB, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study. Circulation. 2005;112(7):969\u201375. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.105.538132.","journal-title":"Circulation"},{"issue":"7","key":"2317_CR28","doi-asserted-by":"publisher","first-page":"806","DOI":"10.4065\/83.7.806","volume":"83","author":"J Danziger","year":"2008","unstructured":"Danziger J. Importance of low-grade albuminuria. Mayo Clin Proc. 2008;83(7):806\u201312. https:\/\/doi.org\/10.4065\/83.7.806.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"2317_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000063718","volume":"14","author":"A S\u0142owik","year":"2002","unstructured":"S\u0142owik A, Turaj W, Iskra T, Strojny J, Szczudlik A. Microalbuminuria in nondiabetic patients with acute ischemic stroke: prevalence, clinical correlates, and prognostic significance. Cerebrovasc Dis. 2002;14(1):15\u201321. https:\/\/doi.org\/10.1159\/000063718.","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"2317_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1053\/j.ajkd.2004.03.022","volume":"44","author":"JI Barzilay","year":"2004","unstructured":"Barzilay JI, Peterson D, Cushman M, et al. The relationship of cardiovascular risk factors to microalbuminuria in older adults with or without diabetes mellitus or hypertension: the cardiovascular health study. Am J kidney Dis. 2004;44(1):25\u201334. https:\/\/doi.org\/10.1053\/j.ajkd.2004.03.022.","journal-title":"Am J kidney Dis"},{"issue":"6","key":"2317_CR31","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","volume":"114","author":"A Goldin","year":"2006","unstructured":"Goldin A, Beckman JA, Schmidt AM, Creager MA. Advanced glycation end products: sparking the development of diabetic vascular injury. Circulation. 2006;114(6):597\u2013605. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.621854.","journal-title":"Circulation"},{"key":"2317_CR32","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","volume":"54","author":"M Brownlee","year":"2005","unstructured":"Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54:1615\u201325.","journal-title":"Diabetes"},{"issue":"12","key":"2317_CR33","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1210\/jc.2017-01922","volume":"102","author":"EJ Barrett","year":"2017","unstructured":"Barrett EJ, Liu Z, Khamaisi M, et al. Diabetic microvascular disease: an endocrine society scientific statement. J Clin Endocrinol Metab. 2017;102(12):4343\u2013410. https:\/\/doi.org\/10.1210\/jc.2017-01922.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2317_CR34","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/ndt\/gfq849","volume":"26","author":"J Anderson","year":"2011","unstructured":"Anderson J, Glynn LG. Definition of chronic kidney disease and measurement of kidney function in original research papers: a review of the literature. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc Eur Ren Assoc. 2011;26(9):2793\u20138. https:\/\/doi.org\/10.1093\/ndt\/gfq849.","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc Eur Ren Assoc"},{"issue":"10","key":"2317_CR35","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.2337\/dc14-1296","volume":"37","author":"KR Tuttle","year":"2014","unstructured":"Tuttle KR, Bakris GL, Bilous RW, et al. Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care. 2014;37(10):2864\u201383. https:\/\/doi.org\/10.2337\/dc14-1296.","journal-title":"Diabetes Care"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02317-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-022-02317-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-022-02317-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T01:08:26Z","timestamp":1648516106000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-022-02317-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,29]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2317"],"URL":"https:\/\/doi.org\/10.1186\/s12916-022-02317-0","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,29]]},"assertion":[{"value":"20 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ACCORD study was conducted in accordance with the principles of the Helsinki declaration. All participants provided written informed consent and the study protocol was approved by a review panel at the National Heart, Lung, and Blood Institute (NHLBI: NCT00000620).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr Gregg Fonarow reports consulting for Abbott, Amgen, AstraZeneca, Bayer, Janssen, Medtronic, Merck, and Novartis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"127"}}